RecruitingNot Applicable

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

United States15 participantsStarted 2017-04-28

Plain-language summary

This trial studies the acceptability and how well decision making tool works in supporting decision making in contralateral prophylactic mastectomy in patients with newly diagnosed breast cancer. Decision making tool may help patients with early stage breast cancer make decisions regarding their surgical options.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Newly diagnosed ductal breast carcinoma in situ (DCIS) or stage I-III sporadic unilateral invasive breast cancer * Able to speak read or write English Exclusion Criteria: * Patients with previous breast cancer * Prior history of bilateral prophylactic mastectomy * Known to have a germline mutation that predisposes them to an increased risk of breast cancer (e.g. BRCA1/2) and/or they are considered at high risk for contralateral breast cancer on the basis of a strong family history of cancer

What they're measuring

Acceptability of the decision support tool

Timeframe: Up to 2 years

Changes in patient's knowledge of contralateral prophylactic mastectomy (CPM)

Timeframe: Baseline up to 2 years

Reductions in decisional conflict about CPM

Timeframe: Baseline up to 2 years

Trial details

NCT IDNCT02918474

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-30

Contact for this trial

Abenaa M Brewster

713-745-4949 abrewster@mdanderson.org

View on ClinicalTrials.gov More Anatomic Stage I Breast Cancer AJCC v8 trials